Vectors TRIZ Cases
- rAAV-shRNA Vector for Heart Failure Gene Therapy
Recombinant adeno-associated virus delivers short hairpin RNA to target myocardial hypertrophy markers.
- AAV Vectors for Adipose Tissue Transduction
Adeno-associated viral vectors use adipose-specific promoters to restrict gene expression, reducing off-target effects in non-adipose organs.
- Inducible CRISPRa/i Nucleic Acid Construct for Multiplexed Gene Regulation
A nucleic acid construct enables inducible expression of orthogonal CRISPR arrays for simultaneous gene activation and repression.
- Synthetic Promoter for Daptomycin Biosynthesis
Replacing native promoters with a novel synthetic variant removes repeat sequences to boost daptomycin production yield.
- Recombinant Vector for Herpesvirus Transactivator Screening
Recombinant expression vector links herpesvirus transactivator to control element, enabling identification of agents disrupting feedback regulation.
- Hepatocyte Gene Therapy for Type 1 Diabetes
Engineered hepatocytes produce insulin via glucose-responsive regulatory elements.
- Autologous NK Cell Reprogramming via Transcription Factor Combinations
Reprogramming somatic cells into autologous natural killer cells using specific transcription factor combinations for scalable immunotherapy production.
- YY1 Multimerization Peptides for Enhancer-Promoter Loop Disruption
Intermediary peptides target YY1 multimers to break enhancer-promoter loops, resolving the trade-off between gene expression control and mechanism complexity.
- HSV Vector PP1α Gene Therapy for Selective TRPV1 Pain Relief
HSV vectors deliver PP1α to neurons, dephosphorylating TRPV1 channels to reduce pain signaling while preserving normal sensory functions.